MIV Therapeutics Inc. (MIVT) CEO, Dr. Mark Landy To Be Featured as Panelist at Medical Design & Manufacturing Minneapolis Conference
9/18/2008 9:56:28 AM
ATLANTA--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB: MIVI, www.mivtherapeutics.com) CEO and President, Dr. Mark Landy, will be featured on a panel at the Medical Design & Manufacturing Minneapolis Conference taking place Tuesday, October 21st through Thursday October 23rd at the Minneapolis Convention Center in Minneapolis, Minnesota. MIV is a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices.
comments powered by